Annual Total Liabilities
$739.69 M
-$2.32 M-0.31%
December 31, 2023
Summary
- As of February 7, 2025, NEO annual total liabilities is $739.69 million, with the most recent change of -$2.32 million (-0.31%) on December 31, 2023.
- During the last 3 years, NEO annual total liabilities has risen by +$445.65 million (+151.56%).
- NEO annual total liabilities is now -2.86% below its all-time high of $761.50 million, reached on December 31, 2021.
Performance
NEO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$732.90 M
+$5.51 M+0.76%
September 30, 2024
Summary
- As of February 7, 2025, NEO quarterly total liabilities is $732.90 million, with the most recent change of +$5.51 million (+0.76%) on September 30, 2024.
- Over the past year, NEO quarterly total liabilities has dropped by -$6.79 million (-0.92%).
- NEO quarterly total liabilities is now -4.71% below its all-time high of $769.14 million, reached on September 30, 2021.
Performance
NEO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NEO Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.3% | -0.9% |
3 y3 years | +151.6% | -4.7% |
5 y5 years | +300.8% | +242.2% |
NEO Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2.9% | at low | -3.8% | +2.2% |
5 y | 5-year | -2.9% | +266.0% | -4.7% | +262.6% |
alltime | all time | -2.9% | >+9999.0% | -4.7% | >+9999.0% |
NeoGenomics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $732.90 M(+0.8%) |
Jun 2024 | - | $727.39 M(+1.5%) |
Mar 2024 | - | $716.93 M(-3.1%) |
Dec 2023 | $739.69 M(-0.3%) | $739.69 M(+1.2%) |
Sep 2023 | - | $730.81 M(-1.1%) |
Jun 2023 | - | $738.92 M(+0.6%) |
Mar 2023 | - | $734.71 M(-1.0%) |
Dec 2022 | $742.01 M(-2.6%) | $742.01 M(-0.1%) |
Sep 2022 | - | $742.59 M(-0.8%) |
Jun 2022 | - | $748.59 M(-0.8%) |
Mar 2022 | - | $754.54 M(-0.9%) |
Dec 2021 | $761.50 M(+159.0%) | $761.50 M(-1.0%) |
Sep 2021 | - | $769.14 M(+2.8%) |
Jun 2021 | - | $747.95 M(+14.9%) |
Mar 2021 | - | $650.70 M(+121.3%) |
Dec 2020 | $294.04 M(+45.5%) | $294.04 M(+0.3%) |
Sep 2020 | - | $293.06 M(+0.6%) |
Jun 2020 | - | $291.26 M(+28.2%) |
Mar 2020 | - | $227.20 M(+12.4%) |
Dec 2019 | $202.10 M(+9.5%) | $202.10 M(-5.6%) |
Sep 2019 | - | $214.15 M(+3.5%) |
Jun 2019 | - | $206.93 M(-1.2%) |
Mar 2019 | - | $209.50 M(+13.5%) |
Dec 2018 | $184.57 M(+32.0%) | $184.57 M(+21.8%) |
Sep 2018 | - | $151.58 M(-16.5%) |
Jun 2018 | - | $181.57 M(+28.5%) |
Mar 2018 | - | $141.26 M(+1.0%) |
Dec 2017 | $139.88 M(-7.1%) | $139.88 M(-3.0%) |
Sep 2017 | - | $144.24 M(+0.6%) |
Jun 2017 | - | $143.31 M(-4.2%) |
Mar 2017 | - | $149.61 M(-0.6%) |
Dec 2016 | $150.52 M(+33.0%) | $150.52 M(+37.7%) |
Sep 2016 | - | $109.33 M(+1.1%) |
Jun 2016 | - | $108.19 M(+1.4%) |
Mar 2016 | - | $106.67 M(-5.7%) |
Dec 2015 | $113.17 M(+446.7%) | $113.17 M(+417.0%) |
Sep 2015 | - | $21.89 M(-0.9%) |
Jun 2015 | - | $22.10 M(+5.2%) |
Mar 2015 | - | $21.00 M(+1.5%) |
Dec 2014 | $20.70 M(+13.7%) | $20.70 M(+4.8%) |
Sep 2014 | - | $19.75 M(-3.7%) |
Jun 2014 | - | $20.50 M(+3.4%) |
Mar 2014 | - | $19.82 M(+8.9%) |
Dec 2013 | $18.20 M(-12.7%) | $18.20 M(+22.2%) |
Sep 2013 | - | $14.90 M(-0.8%) |
Jun 2013 | - | $15.02 M(+1.6%) |
Mar 2013 | - | $14.79 M(-29.1%) |
Dec 2012 | $20.86 M | $20.86 M(+3.9%) |
Sep 2012 | - | $20.08 M(+9.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $18.28 M(+2.9%) |
Mar 2012 | - | $17.77 M(+26.5%) |
Dec 2011 | $14.05 M(+33.6%) | $14.05 M(+15.9%) |
Sep 2011 | - | $12.13 M(+6.6%) |
Jun 2011 | - | $11.37 M(+13.5%) |
Mar 2011 | - | $10.01 M(-4.8%) |
Dec 2010 | $10.52 M(+44.0%) | $10.52 M(-3.6%) |
Sep 2010 | - | $10.91 M(+6.2%) |
Jun 2010 | - | $10.27 M(+12.6%) |
Mar 2010 | - | $9.12 M(+24.8%) |
Dec 2009 | $7.30 M(+26.0%) | $7.30 M(+24.4%) |
Sep 2009 | - | $5.87 M(-16.5%) |
Jun 2009 | - | $7.03 M(+7.8%) |
Mar 2009 | - | $6.52 M(+12.6%) |
Dec 2008 | $5.79 M(+38.0%) | $5.79 M(+4.6%) |
Sep 2008 | - | $5.54 M(+3.9%) |
Jun 2008 | - | $5.33 M(+31.1%) |
Mar 2008 | - | $4.07 M(-3.1%) |
Dec 2007 | $4.20 M(+36.4%) | $4.20 M(+70.6%) |
Sep 2007 | - | $2.46 M(+13.8%) |
Jun 2007 | - | $2.16 M(-37.9%) |
Mar 2007 | - | $3.48 M(+13.2%) |
Dec 2006 | $3.08 M(+48.3%) | $3.08 M(+12.1%) |
Sep 2006 | - | $2.74 M(+13.0%) |
Jun 2006 | - | $2.43 M(+5.7%) |
Mar 2006 | - | $2.30 M(+10.7%) |
Dec 2005 | $2.08 M(+103.7%) | $2.08 M(+22.0%) |
Sep 2005 | - | $1.70 M(+32.7%) |
Jun 2005 | - | $1.28 M(+21.6%) |
Mar 2005 | - | $1.05 M(+3.5%) |
Dec 2004 | $1.02 M(+16.4%) | $1.02 M(+14.0%) |
Sep 2004 | - | $893.80 K(-9.6%) |
Jun 2004 | - | $988.70 K(-3.1%) |
Mar 2004 | - | $1.02 M(+16.7%) |
Dec 2003 | $874.80 K(+106.1%) | $874.80 K(+23.6%) |
Sep 2003 | - | $707.90 K(+21.2%) |
Jun 2003 | - | $584.00 K(+4.3%) |
Mar 2003 | - | $559.70 K(+31.8%) |
Dec 2002 | $424.50 K(+128.0%) | $424.50 K(+13.5%) |
Sep 2002 | - | $374.10 K(-18.4%) |
Jun 2002 | - | $458.60 K(+15.3%) |
Mar 2002 | - | $397.60 K(+113.5%) |
Dec 2001 | $186.20 K(+49.0%) | $186.20 K(-18.1%) |
Sep 2001 | - | $227.40 K(-29.7%) |
Jun 2001 | - | $323.30 K(-31.2%) |
Mar 2001 | - | $470.20 K(+276.2%) |
Dec 2000 | $125.00 K | $125.00 K(-77.4%) |
Sep 2000 | - | $552.20 K(+30.8%) |
Jun 2000 | - | $422.10 K(+25.3%) |
Mar 2000 | - | $336.80 K |
FAQ
- What is NeoGenomics annual total liabilities?
- What is the all time high annual total liabilities for NeoGenomics?
- What is NeoGenomics annual total liabilities year-on-year change?
- What is NeoGenomics quarterly total liabilities?
- What is the all time high quarterly total liabilities for NeoGenomics?
- What is NeoGenomics quarterly total liabilities year-on-year change?
What is NeoGenomics annual total liabilities?
The current annual total liabilities of NEO is $739.69 M
What is the all time high annual total liabilities for NeoGenomics?
NeoGenomics all-time high annual total liabilities is $761.50 M
What is NeoGenomics annual total liabilities year-on-year change?
Over the past year, NEO annual total liabilities has changed by -$2.32 M (-0.31%)
What is NeoGenomics quarterly total liabilities?
The current quarterly total liabilities of NEO is $732.90 M
What is the all time high quarterly total liabilities for NeoGenomics?
NeoGenomics all-time high quarterly total liabilities is $769.14 M
What is NeoGenomics quarterly total liabilities year-on-year change?
Over the past year, NEO quarterly total liabilities has changed by -$6.79 M (-0.92%)